Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 31Esophageal Squamous Cell Carcinoma 17Carcinoma, Squamous Cell 5Adenocarcinoma 3Neoplasms 2Postoperative Complications 1Pathologic Complete Response 1Pain, Postoperative 1Lymphatic Metastasis 1Loco-regional Esophageal Cancer 1Deglutition Disorders 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Anastomotic Leak 1Adenocarcinoma Of Esophagus 1

Interventions

Radiotherapy 4ferric carboxymaltose 3Exercise 3Surgical Procedures, Operative 2Standard of Care 2Sodium Chloride 2Sevoflurane 2Ropivacaine 2Propofol 2Preoperative Exercise 2Oxaliplatin 2Immunonutrition Diet 2Fluorouracil 2Fibrin Tissue Adhesive 2Ethanol 2Dexamethasone 2Counseling 2Bevacizumab 2vapreotide 1streptococcal preparation 722 1methyl N-acetylsibirosaminide 1ferrous sulfate 1Wound Closure Techniques 1World Health Organization oral rehydration solution 1Warm Ischemia 1Vitamin D 1Videotape Recording 1Video-Assisted Surgery 1Tranexamic Acid 1Tracheostomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Postoperative Complications × Esophagectomy × Clear all
NCT04652180 2023-03-01

CIR·ROB

Hospital Universitari de Bellvitge

Phase NA Recruiting
108 enrolled
Gastrointestinal

Esophageal Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡